These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 14623496)
1. Apolipoprotein D modulates arachidonic acid signaling in cultured cells: implications for psychiatric disorders. Thomas EA; George RC; Sutcliffe JG Prostaglandins Leukot Essent Fatty Acids; 2003 Dec; 69(6):421-7. PubMed ID: 14623496 [TBL] [Abstract][Full Text] [Related]
2. Association of plasma apolipoproteins D with RBC membrane arachidonic acid levels in schizophrenia. Yao JK; Thomas EA; Reddy RD; Keshavan MS Schizophr Res; 2005 Jan; 72(2-3):259-66. PubMed ID: 15560970 [TBL] [Abstract][Full Text] [Related]
3. From pharmacotherapy to pathophysiology: emerging mechanisms of apolipoprotein D in psychiatric disorders. Thomas EA; Copolov DL; Sutcliffe JG Curr Mol Med; 2003 Aug; 3(5):408-18. PubMed ID: 12942994 [TBL] [Abstract][Full Text] [Related]
4. Apolipoprotein D Transgenic Mice Develop Hepatic Steatosis through Activation of PPARγ and Fatty Acid Uptake. Labrie M; Lalonde S; Najyb O; Thiery M; Daneault C; Des Rosiers C; Rassart E; Mounier C PLoS One; 2015; 10(6):e0130230. PubMed ID: 26083030 [TBL] [Abstract][Full Text] [Related]
5. Increased CNS levels of apolipoprotein D in schizophrenic and bipolar subjects: implications for the pathophysiology of psychiatric disorders. Thomas EA; Dean B; Pavey G; Sutcliffe JG Proc Natl Acad Sci U S A; 2001 Mar; 98(7):4066-71. PubMed ID: 11274430 [TBL] [Abstract][Full Text] [Related]
6. Clozapine specifically alters the arachidonic acid pathway in mice lacking apolipoprotein D. Thomas EA; Yao JK Schizophr Res; 2007 Jan; 89(1-3):147-53. PubMed ID: 17011169 [TBL] [Abstract][Full Text] [Related]
7. Antipsychotic drugs differentially modulate apolipoprotein D in rat brain. Khan MM; Parikh VV; Mahadik SP J Neurochem; 2003 Sep; 86(5):1089-100. PubMed ID: 12911617 [TBL] [Abstract][Full Text] [Related]
8. Apolipoprotein D is associated with long-term outcome in patients with schizophrenia. Hansen T; Hemmingsen RP; Wang AG; Olsen L; Timm S; Søeby K; Jakobsen KD; Fenger M; Parnas J; Rasmussen HB; Werge T Pharmacogenomics J; 2006; 6(2):120-5. PubMed ID: 16402085 [TBL] [Abstract][Full Text] [Related]
9. Cellular cholesterol storage in the Niemann-Pick disease type C mouse is associated with increased expression and defective processing of apolipoprotein D. Suresh S; Yan Z; Patel RC; Patel YC; Patel SC J Neurochem; 1998 Jan; 70(1):242-51. PubMed ID: 9422368 [TBL] [Abstract][Full Text] [Related]
10. Arachidonic acid binds to apolipoprotein D: implications for the protein's function. Morais Cabral JH; Atkins GL; Sánchez LM; López-Boado YS; López-Otin C; Sawyer L FEBS Lett; 1995 Jun; 366(1):53-6. PubMed ID: 7789516 [TBL] [Abstract][Full Text] [Related]
13. Apolipoprotein D inhibits platelet-derived growth factor-BB-induced vascular smooth muscle cell proliferated by preventing translocation of phosphorylated extracellular signal regulated kinase 1/2 to the nucleus. Sarjeant JM; Lawrie A; Kinnear C; Yablonsky S; Leung W; Massaeli H; Prichett W; Veinot JP; Rassart E; Rabinovitch M Arterioscler Thromb Vasc Biol; 2003 Dec; 23(12):2172-7. PubMed ID: 14551159 [TBL] [Abstract][Full Text] [Related]
14. Elevated plasma level of apolipoprotein D in schizophrenia and its treatment and outcome. Mahadik SP; Khan MM; Evans DR; Parikh VV Schizophr Res; 2002 Nov; 58(1):55-62. PubMed ID: 12363390 [TBL] [Abstract][Full Text] [Related]
15. Apolipoprotein D modulates F2-isoprostane and 7-ketocholesterol formation and has a neuroprotective effect on organotypic hippocampal cultures after kainate-induced excitotoxic injury. He X; Jittiwat J; Kim JH; Jenner AM; Farooqui AA; Patel SC; Ong WY Neurosci Lett; 2009 May; 455(3):183-6. PubMed ID: 19429117 [TBL] [Abstract][Full Text] [Related]
16. Expression of the carrier protein apolipoprotein D in the mouse inner ear. Hildebrand MS; de Silva MG; Klockars T; Solares CA; Hirose K; Smith JD; Patel SC; Dahl HH Hear Res; 2005 Feb; 200(1-2):102-14. PubMed ID: 15668042 [TBL] [Abstract][Full Text] [Related]
17. The Ca2+-sensing receptor (CaR) activates phospholipases C, A2, and D in bovine parathyroid and CaR-transfected, human embryonic kidney (HEK293) cells. Kifor O; Diaz R; Butters R; Brown EM J Bone Miner Res; 1997 May; 12(5):715-25. PubMed ID: 9144337 [TBL] [Abstract][Full Text] [Related]
18. Modulation of apolipoprotein D and apolipoprotein E expression in rat hippocampus after entorhinal cortex lesion. Terrisse L; Séguin D; Bertrand P; Poirier J; Milne R; Rassart E Brain Res Mol Brain Res; 1999 Jun; 70(1):26-35. PubMed ID: 10381540 [TBL] [Abstract][Full Text] [Related]
19. Growth inhibition of human breast cancer cells by 1,25-dihydroxyvitamin D3 is accompanied by induction of apolipoprotein D expression. López-Boado YS; Puente XS; Alvarez S; Tolivia J; Binderup L; López-Otín C Cancer Res; 1997 Sep; 57(18):4091-7. PubMed ID: 9307298 [TBL] [Abstract][Full Text] [Related]
20. Apolipoprotein D mediates autocrine protection of astrocytes and controls their reactivity level, contributing to the functional maintenance of paraquat-challenged dopaminergic systems. Bajo-Grañeras R; Ganfornina MD; Martín-Tejedor E; Sanchez D Glia; 2011 Oct; 59(10):1551-66. PubMed ID: 21688324 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]